Join us as Dr. Anna Barminova describes the use of Tenecteplase (TNK) as an alternative intravenous thrombolytic agent for the treatment of acute ischemic stroke.

Target Audience

Physicians
Advanced Practice Nurses
Physician Assistant
Registered Nurses

Learning Objectives

Learners will be able to;

Describe what Tenecteplase (TNK) is, how it works and how it is different from Alteplase.
Review the clinical evidence for using Tenecteplase (TNK) in Acute Ischemic Stroke (AIS).
Define AHA/ASA current guidelines regarding Tenecteplase (TNK).
Recognize dosing and administration for Tenecteplase (TNK) as well as possible side effects.
Discuss current research and future directions of Tenecteplase (TNK).

Course summary

Available credit:

1.00 AMA PRA Category 1 Credit™
TeleSpecialists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

TeleSpecialists designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
1.00 Nursing Contact Hours
This nursing continuing professional development activity was approved by the Emergency Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Course opens:

01/12/2024

Course expires:

03/19/2024

Event starts:

02/27/2024 - 12:00pm EST

Event ends:

02/27/2024 - 1:00pm EST

Add to calendar:

Rating:

Speaker(s)